PDF herunterladen
Thromb Haemost 1973; 30(01): 084-092
DOI: 10.1055/s-0038-1649104
Original Article
Schattauer GmbH

Quantitative Determination of Total Antithrombin III in Plasma

Robert H. Yue
1   Cardiovascular Research, Institute of Rehabilitation Medicine, New York University Medical Center, New York, New York 10016
,
Toby Starr
1   Cardiovascular Research, Institute of Rehabilitation Medicine, New York University Medical Center, New York, New York 10016
,
Menard M. Gertler
1   Cardiovascular Research, Institute of Rehabilitation Medicine, New York University Medical Center, New York, New York 10016
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received for publication 23. November 1972

Accepted for publication 05. April 1973

Publikationsdatum:
30. Juni 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

A relatively simple method has been developed to evaluate the total amount of antithrombin III in plasma. Since purified and stable bovine thrombin was readily prepared in our laboratory, it was selected to be used in our assay system. Purified α2-macroglobulin was found to inactivate thrombin following a pseudo first-order rate of reaction. However, purified antithrombin III inactivated thrombin following a bimolecular type of reaction. The second-order rate constant for antithrombin III and thrombin interaction was found to be 94 1/M/sec. under these conditions. A least-square straight line was drawn between 15 and 90 minute intervals and the intercept yielded the total amount of antithrombin III expressed NIH thrombin units. This assay system and the graphical analysis yielded the total amount of antithrombin III in plasma quantitatively. The results are reproducible.

 

  • References

  • 1 Abildgaard U. 1967; Purification of two progessive antithrombins of human plasma. Scandinavian Journal of Clinical and Laboratory Investigations 19: 190.
    CrossrefPubMedSuche in Google Scholar
  • 2 Abildgaard TJ. 1969; Binding of thrombin to antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigations 24: 23.
    CrossrefPubMedSuche in Google Scholar
  • 3 Abildgaabd U, Gravem K, and Godal H.C. 1970; Assay of progressive antithrombin in plasma. Thrombosis et Diathesis Haemorrhagica 24: 224.
    PubMedSuche in Google Scholar
  • 4 Astrup T, and Darling S. 1942; Measurement and properties of antithrombin. Acta Physiologica Scandinavica 4: 293.
    CrossrefPubMedSuche in Google Scholar
  • 5 Bertho A, and Grassmann W. 1938. Laboratory Methods of Biochemistry. MacMillan and Co. Ltd.; London: 36.
    Suche in Google Scholar
  • 6 Biggs R, Denson K.W.E, Akman N, Borrett R, and Hadden M. 1970; Antithrombin III, antifactor Xa and heparin. Brithish Journal of Haematology 19: 283.
    PubMedSuche in Google Scholar
  • 7 Dombrose F.A, Seegers W.H, and Sedensky J. A. 1971; Antithrombin: Inhibition of thrombin and autopro thrombin C (F-Xa) as a mutual depletion system. Thrombosis et Diathesis Haemorrhagica 26: 103.
    PubMedSuche in Google Scholar
  • 8 Esnouf M. P, and Williams W. J. 162 The isolation and purification of a bovine-plasma protein which is a substrate of the coagulation fraction of Russell’s-Viper Venom. Biochemical Journal 84: 62.
    PubMed
  • 9 Heimburger N, Haupt H, and Schwick H. G. 1971 Proteinase inhibitor of human plasma. In: Fritz H, and Tschesche H. (ed.) Proceedings of the International Research Conference on Proteinase Inhibitors. Munich, November 4-6, 1970, p. 1.
    PubMedSuche in Google Scholar
  • 10 Heimburger N, and Trobisch H. 1971; Blood Coagulation and Fibrinolysis. Angewandte Chemie International Edition 10: 85.
    PubMedSuche in Google Scholar
  • 11 Monkhouse F. C, France E. S, and Seegers W. H. 1955; Studies on the antithrombin and heparin cofactor activities of a fraction absorbed from plasma by aluminium hydroxide. Circulation Research 3: 397.
    CrossrefPubMedSuche in Google Scholar
  • 12 Quick A.J. 1951. The physiology and pathology of hemostasis. Lea and Febiger; Philadelphia: 168.
    Suche in Google Scholar
  • 13 Seeger W.H. 1968; Antithrombin as a proteinase inhibitor. Annals of the New York Academy of Sciences 146: 593.
    CrossrefPubMedSuche in Google Scholar
  • 14 Seegers W. H, Cole E. R, Harmison C. R, and Monkhouse F. C. 1964; Neuralization of autopro thrombin C activity with antithrombin. Canadian Journal of Biochemistry 42: 359.
    CrossrefPubMedSuche in Google Scholar
  • 15 Seegers N. H, and Marciniak E. 1962; Inhibition of autoprothrombin C activity with plasma. Nature 93: 1188.
    PubMedSuche in Google Scholar
  • 16 Seegers W. H, and Smith H. P. 1943; Antithrombin activity of plasma: quantitative interrelationships. Proceeding of the Society for Experimental Biology 52: 159.
    PubMedSuche in Google Scholar
  • 17 Yin E. T, Wessler S, and Stole P.J. 1971; a Rabbit plasma inhibitor of the activated species of blood coagulation factor X. Purification some properties. Journal of Biological Chemistry 246: 3694.
    PubMedSuche in Google Scholar
  • 18 Yin E.T, Wessler S, and Stoll P.J. 1971; b Biological properties of the naturally occurring plasma inhibitor to activated factor X. Journal of Biological Chemistry 246: 3703.
    PubMedSuche in Google Scholar
  • 19 Yin E.T, Wessler S, and Stoll P. J. 1971; c Identity of plasma-activated factor X inhibitor with antithrombin III and heparin cofactor. Journal of Biological Chemistry 246: 3712.
    PubMedSuche in Google Scholar
  • 20 Yue R.H, Starr T, and Gertler M.M. 1972; The binding of calcium ions to bovine factor X. Federation Proceedings 31: 241 Abstract.
    PubMedSuche in Google Scholar